The CPT code for PNEUMOVAX 23 is 90732.
Prevnar 13 protects against 13 types of bacteria, and Pneumovax 23 protects against 23 types of bacteria. Prevnar 13 is given in the muscle (IM), while Pneumovax 23 can be given either in the muscle (IM) or under the skin (subcutaneously). Most adults over 65 will receive one dose of each vaccine, one year apart.
PCV 13 is available under the brand name Prevnar 13 and PPSV23 is sold as the brand Pneumovax 23. For all adults aged 65 years or older, CDC used to recommend a routine series of Prevnar 13 and Pneumovax 23 vaccines.
ACIP recommends that PCV13 be given first followed by PPSV23 6–12 months later. ACIP also recommends that adults aged ≥65 years who already received a dose of PPSV23, should also receive a dose of PCV13 ≥1 year after the dose of PPSV23.
In some cases, the CDC recommends that certain children and adults get Prevnar 13 in addition to Pneumovax 23. This is usually done if you have a high risk of complications from the bacteria.
CDC recommends you: Administer PCV13 before giving any recommended doses of PPSV23. Ensure the child receives 2 doses of PPSV23. The first dose of PPSV23 should be given at least 8 weeks after any prior PCV13 dose, then the second dose of PPSV23 should be given at least 5 years after the first dose of PPSV23.
Pneumococcal polysaccharide vaccine (PPSV23) can prevent pneumococcal disease. Pneumococcal disease refers to any illness caused by pneumococcal bacteria. These bacteria can cause many types of illnesses, including pneumonia, which is an infection of the lungs.
All adults 65 years of age or older should receive one dose of PPSV23 5 or more years after any prior dose of PPSV23, regardless of previous history of vaccination with pneumococcal vaccine. No additional doses of PPSV23 should be administered following the dose administered at 65 years of age or older.
How often is PNEUMOVAX 23 given? Most often, just one shot is given. If you are in a high-risk group for pneumococcal infection, then your health care provider will decide if it would be helpful to give a second shot of PNEUMOVAX 23 at a later time.
Because PCV13-type disease is at historically low levels among adults ≥65 years and most pneumococcal disease among these adults is due to non-PCV13 serotypes, ACIP no longer recommends their routine vaccination with PCV13.
The Pneumovax 23 covers twenty three different variants of the pneumococcal bacteria. In healthy adults, revaccination is not indicated (necessary). Patients with underlying chronic disease should probably be revaccinated every 5 years. An annual flu shot (influenza vaccine) is probably also indicated.
APIC recommends persons considered to be “high risk” receive the Prevnar 13 vaccine followed by the Pneumovax 23 with 8 weeks in between vaccinations.
65 years old or older: two shots, which will last you the rest of your life. Between 2 and 64 years old: between one and three shots if you have certain immune system disorders or if you're a smoker.
Because PCV13-type disease is at historically low levels among adults ≥65 years and most pneumococcal disease among these adults is due to non-PCV13 serotypes, ACIP no longer recommends their routine vaccination with PCV13.